Palliative Care for Congestive Heart Failure

(PALL-VAD Trial)

This trial explores how palliative care, a supportive care approach, can improve the quality of life for individuals living with a long-term left ventricular assist device (LVAD) due to advanced heart failure. Participants will either continue with their usual LVAD care or receive additional support from a palliative care team, which includes regular visits and access to supportive services like social work or pharmacy. The trial aims to determine if this extra care can alleviate some of the burdens associated with living with an LVAD. It is suitable for those who have had an LVAD for at least a year and are not candidates for a heart transplant. As an unphased trial, this study provides a unique opportunity to explore additional supportive care options that could enhance quality of life.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that palliative care is generally safe for people with heart failure. Studies indicate that this type of care can improve quality of life and emotional well-being without causing major side effects. For example, the PAL-HF trial found that patients who received palliative care experienced better outcomes in terms of depression and anxiety compared to those who received regular care. This suggests that palliative care is well-tolerated and beneficial for heart failure patients.

Researchers are excited about the palliative care intervention for congestive heart failure because it offers a holistic approach that goes beyond the usual care. Unlike standard treatments that primarily focus on managing heart failure symptoms with medications like ACE inhibitors or beta-blockers, this intervention includes regular visits from a specially trained palliative care nurse. These visits occur every 4-6 weeks over six months and involve comprehensive support from a team that could include chaplains, social workers, and pharmacists. This integrated approach aims to improve quality of life by addressing emotional, social, and spiritual needs alongside medical care. Such a multi-disciplinary method could transform how we manage not just symptoms but the overall well-being of heart failure patients.

Research has shown that palliative care can greatly improve the quality of life for people with heart failure. For example, the PAL-HF trial found that patients who received palliative care in an outpatient setting experienced better overall well-being, with less depression and anxiety, compared to those who received standard care. In this trial, participants will join either a palliative care intervention arm or a usual care arm. The palliative care intervention mirrors the approach used in the PAL-HF trial, involving regular visits by a palliative care specialist nurse clinician. A review of several studies also found that palliative care improved health outcomes for people with advanced heart failure. These findings suggest that palliative care could benefit patients living with long-term heart support devices, like left ventricular assist devices (LVADs), and might be an important part of managing advanced heart failure.⁶⁷⁸⁹¹⁰